NCT06095089
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer No drug interventions treatment 1 recruiting NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer No drug interventions treatment 1 recruiting NCT06463457
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) treatment 2 not_yet_recruiting NCT01306890
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Not Available Not Available completed NCT02925702
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. Not Available Not Available unknown_status NCT02420977
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer No drug interventions diagnostic 0 active_not_recruiting NCT01078545
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) Not Available Not Available completed NCT06490328
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer treatment 3 recruiting NCT03577028
Study of HPN424 in Patients With Advanced Prostate Cancer treatment 1 / 2 terminated NCT03651271
Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer treatment 2 completed NCT06555588
Engage Psychosocial Intervention for Cancer Symptoms No drug interventions supportive_care Not Available not_yet_recruiting NCT02787837
PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. No drug interventions Not Available Not Available unknown_status NCT03701659
TUPKRP Combined With MAB Therapy for LUTS/PCa No drug interventions treatment Not Available not_yet_recruiting NCT03938649
SRAM study_Postate Cancer No drug interventions treatment 2 recruiting NCT02922218
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. No drug interventions Not Available Not Available unknown_status NCT03936218
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer treatment 3 recruiting NCT01383863
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer No drug interventions Not Available Not Available completed NCT02234089
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. Not Available Not Available completed NCT05942001
Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) No drug interventions treatment 1 recruiting NCT06006104
Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer No drug interventions treatment 1 / 2 not_yet_recruiting NCT03971110
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. treatment 4 terminated NCT06335914
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT06062745
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT diagnostic 1 recruiting NCT01224405
Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy treatment 3 unknown_status NCT05590793
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate treatment 3 completed NCT00871585
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide No drug interventions Not Available Not Available completed NCT02035124
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel treatment 2 withdrawn NCT03511196
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer treatment 0 active_not_recruiting NCT02362620
PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. No drug interventions Not Available Not Available unknown_status NCT04117594
Whole Body Magnetic Resonance Imaging Study No drug interventions Not Available Not Available unknown_status NCT06369246
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer No drug interventions treatment 2 recruiting